glp 1 agonist route of administration Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Understanding GLP-1 receptor agonists and
Description
Semaglutide is essentially an analogue of liraglutide

Lilly showed in recently announced clinical trial results that patients who switched to orforglipron after losing weight on either Wegovy or Zepbound regained less weight than participants who switched to a placebo

However, adequate adjustment of insulin doses and close monitoring after GLP-1RA initiation may decrease this risk

In another study funded by Novo Nordisk, participants with obesity and overweight but without diabetes took 50 mg of oral semaglutide

This is why GLP-1 is valuable when treating type 2 diabetes
